Home
Reels
Gruppi
Pagine
Mostra tutto
Gruppi Pagine Events Blogs Offers Jobs Courses Movies Merits
Registrati Iscriviti
Theme Switcher
Night Mode
Sponsorizzato
Roche’s HER2-Positive Breast Cancer Therapies: Expanding Leadership in Treatment
Expansion into the Adjuvant Setting Roche has reinforced its position in the HER2-positive breast cancer treatment market by entering the adjuvant therapy space. Approvals for PERJETA and HERCEPTIN in early-stage HER2-positive breast cancer have strengthened the company’s portfolio, offering improved patient outcomes. Combining PERJETA and HERCEPTIN with chemotherapy has become a key...
0 Commenti ·0 condivisioni ·41 Views ·0 Anteprima
Effettua l'accesso per mettere mi piace, condividere e commentare!
Sponsorizzato
Passa a Pro
Scegli il piano più adatto a te
AGGIORNA
Sponsorizzato
Sponsorizzato